(3aS,8aS)-1,3a-dimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate

ID: ALA1241427

Chembl Id: CHEMBL1241427

PubChem CID: 21589046

Max Phase: Preclinical

Molecular Formula: C14H19N3O2

Molecular Weight: 261.32

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2

Standard InChI:  InChI=1S/C14H19N3O2/c1-14-6-7-17(3)12(14)16-11-5-4-9(8-10(11)14)19-13(18)15-2/h4-5,8,12,16H,6-7H2,1-3H3,(H,15,18)/t12-,14-/m0/s1

Standard InChI Key:  GPONHWSDHNCYFZ-JSGCOSHPSA-N

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SHMT2 Tchem Serine hydroxymethyltransferase, mitochondrial (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 261.32Molecular Weight (Monoisotopic): 261.1477AlogP: 1.75#Rotatable Bonds: 1
Polar Surface Area: 53.60Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.28CX LogP: 1.60CX LogD: 1.57
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.81Np Likeness Score: 1.03

References

1. Chaudhaery SS, Roy KK, Shakya N, Saxena G, Sammi SR, Nazir A, Nath C, Saxena AK..  (2010)  Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology.,  53  (17): [PMID:20684567] [10.1021/jm100573q]
2.  (2016)  Compositions and methods relating to inhibiting serine hyrdoxymethyltransferase 2 activity,